Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lipopolysaccharide results in a marked decrease in hepatocyte nuclear factor 4 alpha in rat liver.

B Wang1, S R Cai, C Gao

  • 1Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO, USA.

Hepatology (Baltimore, Md.)
|October 27, 2001
PubMed
Summary

Lipopolysaccharide (LPS) reduces hepatocyte nuclear factor 4 alpha (HNF-4 alpha) in rat livers, impairing liver function. Interleukin-1 beta (IL-1 beta) likely causes this decrease via proteasome degradation, suggesting therapeutic targets.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Reconstruction of larynx with epiglottis and strip muscular flap after extended partial laryngectomy with T3 category].

Zhonghua er bi yan hou ke za zhi·2000
Same author

Hypersensitivity or development of antibodies to asparaginase does not impact treatment outcome of childhood acute lymphoblastic leukemia.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2000
Same author

Development of an ELISA for paraquat; improvement of antibody characteristics by reversed affinity chromatography.

The Analyst·2000
Same author

Stepwise development of thymic microenvironments in vivo is regulated by thymocyte subsets.

Development (Cambridge, England)·2000
Same author

HIV-1 strains from a cohort of American subjects reveal the presence of a V2 region extension unique to slow progressors and non-progressors.

AIDS (London, England)·2000
Same author

[Expression of FADD in primary hepatocellular carcinoma and its relationship with hepatic apoptosis].

Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology·2000

Area of Science:

  • Hepatology
  • Molecular Biology
  • Immunology

Background:

  • The acute-phase response can lead to liver failure and decreased liver function.
  • Lipopolysaccharide (LPS) triggers the acute-phase response and reduces liver-specific functions.
  • Hepatocyte nuclear factor 4 alpha (HNF-4 alpha) is crucial for liver-specific gene expression.

Purpose of the Study:

  • To investigate the effect of LPS on HNF-4 alpha levels in rat livers.
  • To elucidate the mechanism behind LPS-induced HNF-4 alpha reduction.
  • To explore the role of Interleukin-1 beta (IL-1 beta) in this process.

Main Methods:

  • Administered LPS to rats and analyzed HNF-4 alpha levels in liver tissue.
  • Examined mRNA levels and splicing patterns of HNF-4 alpha.

Related Experiment Videos

  • Treated HepG2 cells with IL-1 beta and proteasome inhibitor MG132 to assess HNF-4 alpha degradation.

    • Main Results:

    • LPS administration significantly decreased HNF-4 alpha protein levels in rat livers.
    • The decrease in HNF-4 alpha was post-transcriptional, with normal mRNA levels and splicing.
    • IL-1 beta reduced HNF-4 alpha in HepG2 cells, an effect blocked by MG132, indicating proteasomal degradation.

    Conclusions:

    • LPS-induced reduction of HNF-4 alpha in vivo may be mediated by IL-1 beta.
    • IL-1 beta-induced proteasomal degradation of HNF-4 alpha contributes to liver insufficiency during the acute-phase response.
    • Targeting IL-1 beta or proteasome degradation could potentially improve liver function and survival during the acute-phase response.